Please browse our latest news, for information from around the firm and updates on our recent work.
For more information, please contact Orla O'Donovan, PR Manager.
Charles Russell Speechlys advises on sale of dental practice Feltham Dental
Feltham Dental was established in 1982, the business is an integral part of the community and has many generations of loyal patients.
Charles Russell Speechlys advises Wimbledon NeuroCare and Ascot Rehabilitation on the acquisition of a healthcare diagnostic centre
Both Ascot Rehab and Wimbledon NeuroCare provide high quality rehabilitation services for people with neurological conditions.
Publication of the Third edition of Lissack and Horlick on Bribery and Corruption
The Third edition has been published by LexisNexis Butterworths and features two members of our Commercial Dispute Resolution Team.
Charles Russell Speechlys sponsor The Sunday Times Fast Track 100 ‘Outstanding Achievement’ award
Taking a glimpse into the 23rd Sunday Times Fast Track virtual conference and awards dinner.
Charles Russell Speechlys advises LiDCO Group plc on its £30m share premium account cancellation
LiDCO, a UK-based group manufactures and supplies invasive, minimally and non-invasive hemodynamic monitoring equipment.
Charles Russell Speechlys advises Oracle Power plc on £46.5m placing and subscription deed
Oracle Power PLC is a UK based company involved in the exploration for and development of coal in Pakistan.
Charles Russell Speechlys releases H1 2020 deal highlights
Our highlights over the past 6 months are now available.
Charles Russell Speechlys advises Transense Technologies Plc on iTrack technology transaction with Bridgestone Corporation
Transense Technologies Plc, the provider of sensor systems for the industrial, mining and transportation markets.
Charles Russell Speechlys advises Grant Thornton as nomad and Tamesis, Ashanti and Azure as joint bookrunners on Trident Resources plc’s admission to AIM
Trident Resources plc is a growth-focused diversified mining royalty and streaming company.
Charles Russell Speechlys advises Kreos and SVB on $70m private placement for AIM listed Mereo BioPharma Group plc
Mereo BioPharma is a clinical stage UK-based biopharmaceutical company listed on the AIM market of the LSE.